XML 12 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (2,999,959) $ (2,492,817)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 50,052 16,314
Stock based compensation 419,995 86,152
Warrant issued for product development agreement 0 1,399,833
Changes in operating assets and liabilities:    
Accounts receivable (164,600) 19,663
Prepaid expenses (1,079,467) (26,185)
Accounts payable and accrued expenses 980,679 (78,558)
Deferred revenue 200,109 0
Other liabilities (5,002) 22,007
Cash Provided by (Used In) Operating Activities (2,598,193) (1,053,591)
Cash Flows from Investing Activities    
Purchase of marketable securities (5,998,243) 0
Purchase of equipment (125,011) (2,319)
Proceeds from reverse acquisition 0 29,536
Increase in other asset (1,745) (19,826)
Cash Provided by (Used In) Investing Activities (6,123,999) 7,391
Cash Flow from Financing Activities    
Repayments to (advances) from stockholders 0 (15,108)
Proceeds from sale of series D preferred shares 0 6,551,745
Proceeds from exercise of options and warrants 0 1,285,344
Cash Provided by Financing Activities 0 7,821,981
Net Increase in Cash (8,723,192) 6,775,781
Cash, Beginning of the Period 11,131,175 71,799
Cash, End of the Period 2,407,983 6,847,580
NON-CASH FINANCING ACTIVITIES    
Conversion of preferred stock to common stock 133 0
License 0 1,073,529
Accounts payable settled with Series D Preferred Stock 0 50,000
NET LIABILITIES ASSUMED IN REVERSE ACQUISITION    
Cash 0 29,536
Prepaid expense 0 14,483
Accounts receivable 0 1,000
Account payable 0 (46,150)
Accrued expenses 0 (83,094)
Net liability assumed $ 0 $ (84,225)